CRIS Current Research Information System

MARTIGNANI, CRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.712
AS - Asia 10.622
EU - Europa 9.287
SA - Sud America 608
AF - Africa 607
Continente sconosciuto - Info sul continente non disponibili 502
OC - Oceania 21
Totale 34.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.520
VN - Vietnam 3.174
SG - Singapore 2.799
CN - Cina 2.432
GB - Regno Unito 2.221
IT - Italia 2.216
DE - Germania 1.175
HK - Hong Kong 770
UA - Ucraina 717
SE - Svezia 674
FR - Francia 616
RU - Federazione Russa 504
IN - India 481
BR - Brasile 410
IE - Irlanda 276
NL - Olanda 213
JP - Giappone 202
CI - Costa d'Avorio 191
EE - Estonia 182
KR - Corea 173
FI - Finlandia 161
ZA - Sudafrica 161
BD - Bangladesh 136
CA - Canada 89
TG - Togo 85
AR - Argentina 80
SC - Seychelles 75
PH - Filippine 72
CH - Svizzera 63
BG - Bulgaria 58
JO - Giordania 54
TH - Thailandia 45
IQ - Iraq 43
MX - Messico 41
NG - Nigeria 40
BE - Belgio 38
ID - Indonesia 35
AT - Austria 32
IR - Iran 31
CO - Colombia 30
EC - Ecuador 30
PL - Polonia 28
TR - Turchia 26
PK - Pakistan 25
SA - Arabia Saudita 24
TW - Taiwan 24
GR - Grecia 21
AU - Australia 19
CL - Cile 18
ES - Italia 17
RO - Romania 15
UZ - Uzbekistan 15
EG - Egitto 14
JM - Giamaica 14
PY - Paraguay 12
MY - Malesia 11
MA - Marocco 10
VE - Venezuela 10
CR - Costa Rica 8
PE - Perù 8
UY - Uruguay 8
CZ - Repubblica Ceca 7
HN - Honduras 7
LT - Lituania 7
NP - Nepal 7
DZ - Algeria 6
GT - Guatemala 6
KE - Kenya 6
KZ - Kazakistan 6
LB - Libano 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
AL - Albania 4
ET - Etiopia 4
HR - Croazia 4
HU - Ungheria 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TN - Tunisia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
LU - Lussemburgo 3
MN - Mongolia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
GP - Guadalupe 2
KG - Kirghizistan 2
LV - Lettonia 2
Totale 33.830
Salva come PNG Salva come JPEG
Città #
Singapore 1.935
Southend 1.919
Ashburn 1.216
San Jose 1.061
Fairfield 954
Hong Kong 727
Chandler 632
Ho Chi Minh City 588
Santa Clara 538
Jacksonville 526
Wilmington 495
Hanoi 466
Seattle 456
Dong Ket 449
Woodbridge 445
Princeton 442
Houston 430
Council Bluffs 360
Hefei 344
Beijing 319
Cambridge 310
Ann Arbor 285
Dublin 277
Boardman 273
Los Angeles 269
Lauterbourg 210
New York 203
Westminster 201
Padova 200
Nanjing 197
Abidjan 191
Tokyo 184
Milan 181
Bologna 177
Helsinki 139
Seoul 130
Rome 129
Berlin 122
Saint Petersburg 112
Buffalo 110
Dallas 104
Shenyang 103
Medford 101
Jinan 93
Bremen 92
Changsha 90
Lomé 85
Mülheim 82
Da Nang 76
Turin 75
San Diego 71
Mahé 67
Haiphong 64
Nanchang 64
Chicago 63
Frankfurt am Main 63
São Paulo 61
Guangzhou 57
Sofia 57
Munich 54
Hebei 53
Amman 51
Redondo Beach 48
The Dalles 44
Bern 43
Des Moines 43
Olalla 43
Jiaxing 42
Tianjin 42
Naples 41
Phoenix 41
Abeokuta 38
Shanghai 37
Verona 37
Zhengzhou 37
Bari 35
Bengaluru 33
Brussels 33
Hải Dương 33
Hangzhou 32
Ningbo 31
San Francisco 29
Biên Hòa 28
London 27
Yubileyny 27
Can Tho 26
Brooklyn 25
Falkenstein 25
Florence 25
Atlanta 24
Norwalk 24
Haikou 22
Mountain View 22
Ninh Bình 22
Toronto 22
Dearborn 21
Taizhou 21
Montreal 20
Nuremberg 20
Orem 20
Totale 21.011
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.136
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 315
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 292
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 275
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 269
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 259
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 256
Technical Suitability of Implantable Cardiac Devices for Recreational Diving 241
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 239
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 237
AF burden is important - Fact or fiction? 232
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 225
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 221
Aritimie cardiache, morte cardiaca improvvisa, sincope 219
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 217
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 213
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 212
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 212
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 208
Electrocardiographic remodeling during cardiac resynchronization therapy 207
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 207
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 202
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 201
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 200
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 200
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 196
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 195
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 194
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 193
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 191
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 189
Atrial fibrillation ablation: beyond electro-mechanical matters 188
Implantation of cardioverter-defibrillator: Effects on shoulder function. 184
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 183
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 183
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 183
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 183
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 182
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 182
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 182
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 181
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 180
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 179
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 179
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 179
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 178
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 178
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 176
Rate control in AFFIRM: considerations about the clinical implications. 175
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 175
Pacing with capture verification in candidates for resynchronisation therapy: a feasibility study. 174
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 174
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 173
Predictors of long-term survival free from relapses after extraction of infected CIED. 173
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 173
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 172
Is ventricular sensing always right, when it is left? 171
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 170
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 167
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 164
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 164
Atrial fibrillation and heart failure: does one epidemic feed he other? 164
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 163
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 163
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 162
Poor Glycaemic Control and Arrhythmias. 162
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 162
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 162
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 161
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 159
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 158
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 158
Phrenic stimulation: a challenge for cardiac resynchronization therapy 158
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 158
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 157
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 157
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. 157
Shoulder Function After Cardioverter-Defibrillator Implantation: 5-Year Follow-up 156
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 155
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 155
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 155
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 154
The QRS interval in patients treated with resynchronization therapy: which value 153
Follow-up a lungo termine di pazienti con sincope valutati con tilt test 152
Single versus dual-chamber ICDs : evaluation of rhythm discrimination QRS morphology. 151
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 151
A plateau waveform shape allows a much higher patient shock energy tolerance 151
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 151
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 151
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 151
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet? 150
Risultati e complicanze dell'impianto di cardioverter-defibrillatore in pazienti con cardiomiopatia aritmogena del ventricolo destro. 150
Risultati a lungo termine della cardioversione elettrica di fibrillazione o flutter atriale. 150
Atrioventricular Block Treatment: Pacing Site, AV Synchrony, or Both? 149
Is cardiac resynchronization therapy cost-effective? 149
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 149
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 149
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 149
Cardiac resynchronization by pacing: an electrical treatment of heart failure 149
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 148
Totale 19.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.677 0 0 0 292 326 228 48 271 104 154 607 647
2022/20233.769 365 452 189 501 217 221 115 196 666 218 319 310
2023/20241.162 93 178 88 79 119 228 83 75 62 58 40 59
2024/20254.275 189 797 318 312 801 196 189 111 56 268 177 861
2025/20269.868 887 854 949 678 1.005 579 1.115 681 1.687 744 331 358
2026/20271.735 337 331 869 198 0 0 0 0 0 0 0 0
Totale 34.359